Back to search results

Peptamen Intense VHP for Obese Tube-Fed Patients

This study is looking at how a special tube feeding formula, Peptamen Intense VHP, affects body weight in people who are obese and receive their nutrition through a tube (Home Enteral Nutrition or HEN). Peptamen Intense VHP is higher in protein and lower in carbohydrates than standard formulas. Researchers want to see if this formula helps with weight loss, how well people tolerate it, and its impact on muscle mass, blood pressure, blood sugar, and fats in the blood. To join, you must be an adult HEN patient getting most of your nutrition through a tube, have a body mass index (BMI) over 30, have a history of stroke, and have had a stable weight for the past month. The study is currently unclear on its status.

Study design
This is an interventional study with a planned enrollment of 12 participants. It is not specified if it is randomized or blinded.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Body weight will be measured at the beginning of the study and again after 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05080699

Evaluating Benefit of Peptide Based Diet in Obese HEN Patients

Enrolling by Invitation
NAAges 18+InterventionalTreatment
Mayo Clinic
~12 participants
Updated 2026-01-26 on ClinicalTrials.gov
What's tested:Peptamen Intense VHP, Nestlé Health Science, Switzerland

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in body weight
Measured over Baseline, 3 months

Conditions

Obesity

Explore related trials

Enteral feedingObesityStroke

NCT05080699

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Mayo Clinic in Rochester

    Rochester, Minnesotano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Manpreet Mundi, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Home Enteral Nutrition (HEN) patient receiving at least 90% of energy needs from enteral nutrition.
BMI \> 30.
History of stroke.
Weight stable over the past month.

Exclusion

Diagnosis of cancer undergoing active treatment (chemotherapy, radiation, immunotherapy).
Life expectancy of less than 6 months.
Stage IV or higher kidney disease (GFR \< 30).

What this trial measures

  • Change in body weightBaseline, 3 months

    Change in body weight, measured in kg